Pharmacy benefit managers (PBMs), who are a powerful force in the prescription drug industry, have a huge impact on affordability and accessibility. A new report by the Federal Trade Commission (FTC), which was released last week, found that “these powerful middlemen” may be profiting from inflating the cost of drugs and squeeze Main Street pharmacies.
In a shocking new report from the Federal Trade Commission (FTC ),” these powerful middlemen may be profiting by inflating drug costs and squeezing Main Street pharmacies,” PBMs have a lot of power over the accessibility and affordability of prescription drugs. The report indicates a major increase in scrutiny of the… In a shocking new report from the Federal Trade Commission (FTC ),” these powerful middlemen may be profiting by inflating drug costs and squeezing Main Street pharmacies,” PBMs have a lot of power over the availability and affordability of prescription drugs. The report indicates a major increase in scrutiny of the business practices of…
Pharmacy benefit managers (PBMs), who are a powerful force in the prescription drug industry, have a huge impact on affordability and accessibility. A new report by the Federal Trade Commission (FTC), which was released last week, found that “these powerful middlemen” may be profiting from inflating the cost of drugs and squeeze Main Street pharmacies.
